With 350 employees, the company is currently valued at close to USD 7 billion (as of Nov 28, 2024). The company collaborates with a wide range of partners to offer quantum applications in the cloud, including Microsoft, Amazon and Google.

We want to build a small but strong team, primarily for application development in quantum computational chemistry. We are looking for computational chemists at doctoral level, but also entrepreneurs and engineers who are interested in pursuing a career in quantum technology.

“Sweden has a clear growth strategy in quantum technology. The quality of the expertise, the strength of the universities in Gothenburg as well as the significant R&D footprint of large enterprises in the Gothenburg region, positions Gothenburg as a great location for innovative deep tech companies like IonQ. Here we have also been able to align closely with the national strategy and work with Business Region Göteborg, which has opened up highly interesting collaboration opportunities for us,” says Lorenzo Roversi, of IonQ AB. “We start recruiting immediately and want to build a small but strong team, primarily for application development in quantum computational chemistry. We are looking for computational chemists at doctoral level, but also entrepreneurs and engineers who are interested in pursuing a career in quantum technology.”

Plans include a potential collaboration with AstraZeneca with the aim of exploring interesting quantum applications in chemistry and drug development.

Related article

Quantum computing – Solving the most complex life science issues

The power of quantum computing holds great promise for the life science industry, not least speeding up and reducing costs within drug discovery. McKinsey & Company describes quantum computing like this in one of their Insight articles (What is quantum computing? 2023): “Classic computing is built on bits while quantum computing is built on quantum […]


“We are thrilled to welcome IonQ to BioVentureHub. The potential of applying quantum computing in Life Science is immense, for example in chemistry, where this technology could pave the way for groundbreaking advancements. Exploring this area aligns perfectly with our commitment to sustainable chemistry development,” says Magnus Björsne, Head of AstraZeneca’s BioVenture Innovation Unit and CEO of AstraZeneca BioVentureHub.

Related article

International center for medical quantum sensing to be established in Copenhagen

The Novo Nordisk Foundation has awarded a grant of DKK 150 million to establish the Copenhagen Center for Biomedical Quantum Sensing. The centre aims to develop novel quantum sensing principles and techniques for early detection of diseases. It will be located with the Niels Bohr Institute, the physics department at Copenhagen Science City-partner University of […]


IonQ hopes that progress in Gothenburg will make the Swedish activities pioneering the company’s global development in chemical calculations, it states. At the same time, contacts have already been made with a number of other Swedish industrial companies that can benefit from quantum computers in various ways.

The American company, based in Maryland, has established what it states is the world’s first serial production facility for quantum computers in Seattle, Washington.